5-(DIMETHYLAMINO)-2-(3-NITROPHENYL)-1,3-DITHIANE-2-CARBONITRILE


Source	Gaulton A, Kale N, van Westen GJ, Bellis LJ, Bento AP, Davies M, Hersey A, Papadatos G, Forster M, Wege P, Overington JP. A large-scale crop protection bioassay data set. Sci Data. 2015 Jul 7;2:150032. Read more ...


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	QVKKKYLCYKPIKA-UHFFFAOYSA-N
Smiles	CN(C)C1CSC(SC1)(C#N)c2cccc(c2)[N+](=O)[O-]
InChI	InChI=1S/C13H15N3O2S2/c1-15(2)12-7-19-13(9-14,20-8-12)10-4-3-5-11(6-10)16(17)18/h3-6,12H,7-8H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C13H15N3O2S2
Molecular Weight	309.41
AlogP	3.0
Hydrogen Bond Acceptor	6.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	3.0
Polar Surface Area	123.44
Molecular species	NEUTRAL
Aromatic Rings	1.0
Heavy Atoms	20.0

Assay Description	Organism	Bioactivity
Insecticidal activity against third-instar larvae of Henosepilachna vigintioctopunctata assessed as mortality after 2 days	Henosepilachna vigintioctopunctata	15.0 ppm
Insecticidal activity against Tetranychus urticae (two-spotted spider mite) in kidney bean plant leaf assessed as mortality at 500 ppm after 2 days	Tetranychus urticae	100.0 %
Insecticidal activity against 3rd instar larva of Laodelphax striatella (small brown planthopper) assessed as mortality at 50 ppm after 6 days	Laodelphax striatella	70.0 %
Insecticidal activity against 5th instar larva of Chilo suppressalis assessed as mortality at 50 ug/g after 48 hr	Chilo suppressalis	100.0 %

Cross References

Resources	Reference
ChEMBL	CHEMBL2285770
PubChem	13488488

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).